AmeriServ Financial Inc.: Approximately 701,600 shares changed hands, a 2,806.8 percent increase over its 65- day average volume. The shares fell$. 06 or 2.0 percent to $2.95. Celsion Corp.: Approximately 7,095,600 shares changed hands, a 9,551.5 percent increase over its 65- day average volume.
Celsion shares were downgraded Thursday, right in front of an announcement of clinical trial results for its Thermodox liver cancer therapy.
TheStreet.com details the 10 best-performing biopharmaceutical stocks of 2012 and their outlook for 2013.
Hedge funds peeled back the curtain this week to reveal a bit about what biotech stocks they were buying and selling during the second quarter.